Bessemer Group Inc Sage Therapeutics, Inc. Transaction History

Bessemer Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$27.52 - $37.99 $2,229 - $3,077	-81 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$70.65 - $96.76 $5,722 - $7,837	81 New	81 $6,000
Q1 2019 May 13, 2019	SELL	$89.33 - $163.65 $37,161 - $68,078	-416 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$81.94 - $139.71 $2,785 - $4,750	34 Added 8.9%	416 $40,000
Q3 2018 Nov 06, 2018	BUY	$138.11 - $169.04 $52,758 - $64,573	382 New	382 $54,000
Q4 2017 Jan 30, 2018	SELL	$60.72 - $167.34 $137,409 - $378,690	-2,263 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$61.4 - $88.52 $138,948 - $200,320	2,263	2,263 $141,000

194

45M

304K

117K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $440M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.